JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
AbbVie
ABBV
|
+$1.02B |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$827M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.43B |
| 2 |
Amazon
AMZN
|
+$1.85B |
| 3 |
Cigna
CI
|
+$1.16B |
| 4 |
Microsoft
MSFT
|
+$1.08B |
| 5 |
Morgan Stanley
MS
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.67% |
| 2 | Technology | 15.47% |
| 3 | Financials | 11.13% |
| 4 | Healthcare | 9.58% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IBDQ
5801
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $23K | ﹤0.01% |
853
-3,609
| -81% | -$97.3K |
2019 Q4
7 quarters
|
|
5802
Momentus
MNTS
$74.2M
| – | – |
-3
| Closed | -$399K | – |
|
5803
Owlet
OWLT
$136M
| $23K | ﹤0.01% |
+289
| New | +$32.3K |
2021 Q3
0 quarters
|
|
5804
Tango Therapeutics
TNGX
$3.81B
| $23K | ﹤0.01% |
+1,812
| New | +$21.7K |
2021 Q3
0 quarters
|
|
5805
Travelzoo
TZOO
$54.7M
| $23K | ﹤0.01% |
1,972
+507
| +35% | +$6.44K |
2016 Q2
21 quarters
|
|
|
OKUR
5806
OnKure Therapeutics
OKUR
$93.1M
| $23K | ﹤0.01% |
312
-467
| -60% | -$39.6K |
2021 Q2
1 quarter
|
|
|
ETACW
5807
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
| – | – |
0
| – | – |
2021 Q1
2 quarters
|
|
5808
PUT
BP
BP
$119B
| $22K | ﹤0.01% |
800
-109,200
| -99% | -$2.74M |
2021 Q2
1 quarter
|
|
5809
China Yuchai International
CYD
$1.09B
| $22K | ﹤0.01% |
1,655
+1,500
| +968% | +$21.8K |
2020 Q3
4 quarters
|
|
5810
PUT
Community Health Systems
CYH
$385M
| $22K | ﹤0.01% |
1,900
| – | – |
2020 Q4
3 quarters
|
|
5811
CALL
Caesars Entertainment
CZR
$6.02B
| $22K | ﹤0.01% |
200
-224,800
| -100% | -$22M |
2019 Q1
10 quarters
|
|
5812
CALL
PENN Entertainment
PENN
$2.11B
| $22K | ﹤0.01% |
300
+100
| +50% | +$7.35K |
2021 Q1
2 quarters
|
|
5813
TROOPS Inc
TROO
$192M
| $22K | ﹤0.01% |
+3,880
| New | +$29.2K |
2021 Q3
0 quarters
|
|
|
NVCN
5814
DELISTED
Neovasc Inc.
NVCN
| $22K | ﹤0.01% |
1,229
-32
| -3% | -$641 |
2019 Q2
9 quarters
|
|
5815
Vanguard Total World Bond ETF
BNDW
$1.85B
| $21K | ﹤0.01% |
268
-23
| -8% | -$1.86K |
2021 Q1
2 quarters
|
|
5816
Schwab Fundamental US Large Company Index ETF
FNDX
$27.6B
| $21K | ﹤0.01% |
1,194
| – | – |
2018 Q3
12 quarters
|
|
5817
VanEck India Growth Leaders ETF
GLIN
$85.2M
| $21K | ﹤0.01% |
500
| – | – |
2021 Q1
2 quarters
|
|
5818
LENSAR
LNSR
$79.2M
| $21K | ﹤0.01% |
2,727
-1,500
| -35% | -$12.2K |
2020 Q4
3 quarters
|
|
5819
OppFi
OPFI
$519M
| $21K | ﹤0.01% |
+2,661
| New | +$23.4K |
2021 Q3
0 quarters
|
|
5820
iShares MSCI India Small-Cap ETF
SMIN
$707M
| $21K | ﹤0.01% |
346
+96
| +38% | +$5.51K |
2021 Q1
2 quarters
|
|
5821
Turkcell
TKC
$4.46B
| $21K | ﹤0.01% |
4,903
+2,083
| +74% | +$9.62K |
2021 Q1
2 quarters
|
|
5822
Value Line
VALU
$408M
| $21K | ﹤0.01% |
621
-627
| -50% | -$20.8K |
2017 Q4
15 quarters
|
|
|
AUC
5823
ATIF Holdings
AUC
$94.4M
| $21K | ﹤0.01% |
+256
| New | +$17.7K |
2021 Q3
0 quarters
|
|
|
SCPS
5824
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
| $21K | ﹤0.01% |
5,000
-4,338
| -46% | -$22.3K |
2021 Q1
2 quarters
|
|
|
XPOA.WS
5825
DELISTED
DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at
XPOA.WS
| – | – |
0
| – | – |
2021 Q2
1 quarter
|
|
Similar funds
JP Morgan Chase's Q3 2021 Portfolio in Review
As of Q3 2021, JP Morgan Chase held 7,104 positions worth $809B, down 3.5% from $838B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2021 filing shows 647 new, 2,077 increased, 3,085 reduced and 500 closed positions. Its largest new stake was Toast: 2,760,295 shares worth $138M. The largest sale was Apple, an estimated $2.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2021 buy was Toast: 2,760,295 shares worth $138M.
- JP Morgan Chase added most to Vanguard Short-Term Bond ETF in Q3 2021, an estimated $5.57B increase.
- JP Morgan Chase's biggest Q3 2021 reduction was Apple, cutting an estimated $2.43B.
- JP Morgan Chase fully exited Weingarten Realty Investors in Q3 2021, selling an estimated $401M.
- JP Morgan Chase's ten largest holdings make up 16% of its $809B portfolio in Q3 2021.
- JP Morgan Chase opened 647 new positions and closed 500 in Q3 2021.
- JP Morgan Chase's portfolio value fell 3.5% quarter-over-quarter to $809B.
Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.